Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimensMarie Sébert,Lucie Freiman,Cendrine Chaffaut,Agnès Guerci,Pierre Peterlin,Sylvain Thépot,Odile Beyne-Rauzy,Sophie Park,Thomas Cluzeau,Fatiha Chermat,Pierre Fenaux,Claude Preudhomme,Emmanuelle Clappier,Sylvie Chevret,Lionel Adès,Nicolas Duployez,Matthieu DuchmannLeukemia(2024)引用 0|浏览32暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要